How should an oncologist respond to a patient’s fear of death?
By Mikkael Sekeres, MD, MS
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Three-quarters of the way through inpatient rounds, my team and I stopped to see our patient, a woman in her 50s who had been given a diagnosis of acute lymphocytic leukemia and had been started on chemotherapy over three weeks earlier. She had been doing well and her blood counts were starting to recover, so she would soon go home.
Her eyes were anxious, though, and she wrung her hands.
I met her eyes, and smiled a bit. “You’ve done great throughout your chemotherapy course, you’re on minimal medications, and your bone marrow is recovering. We aren’t at all nervous about you,” I said. “Why are you worried?”
She exhaled, though I couldn’t tell if she did so because she was relieved to hear about her good health, or frustrated that she had to repeat herself. “I’ve seen family members die in the hospital and I don’t want that to happen to me,” she said. “Promise me I won’t die here.”
Read the full New York Times column by Dr. Sekeres, Director of Cleveland Clinic Cancer Center’s Leukemia Program.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients